B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.

MLA

Daoussis, Dimitrios, et al. “B-Cell Depletion Therapy in Patients with Diffuse Systemic Sclerosis Associates with a Significant Decrease in PDGFR Expression and Activation in Spindle-like Cells in the Skin.” Arthritis Research & Therapy, vol. 14, no. 3, June 2012, p. R145. EBSCOhost, https://doi.org/10.1186/ar3879.

APA

Daoussis, D., Tsamandas, A. C., Liossis, S.-N. C., Antonopoulos, I., Karatza, E., Yiannopoulos, G., & Andonopoulos, A. P. (2012). B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin. Arthritis Research & Therapy, 14(3), R145. https://doi.org/10.1186/ar3879

Chicago

Daoussis, Dimitrios, Athanassios C Tsamandas, Stamatis-Nick C Liossis, Ioannis Antonopoulos, Elli Karatza, Georgios Yiannopoulos, and Andrew P Andonopoulos. 2012. “B-Cell Depletion Therapy in Patients with Diffuse Systemic Sclerosis Associates with a Significant Decrease in PDGFR Expression and Activation in Spindle-like Cells in the Skin.” Arthritis Research & Therapy 14 (3): R145. doi:10.1186/ar3879.